Higher circulating levels of fetuin-A can affect obesity, metabolic syndrome, and insulin resistance/T2D (12), and fetuin A has roles in the development of T2DM, metabolic disorders, NAFLD, cardiovascular diseases (CVD), some types of cancers, and some brain disorders (13). This evidence concerns the gene AHSG and brain disorder.